Clinical Trial to Assess the Efficacy of Reducing the Aligners' Wear Protocol on the Predictability of Orthodontic Tooth Movement

Sponsor
University of Florida (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05905224
Collaborator
Align Technology, Inc. (Industry)
40
2
24

Study Details

Study Description

Brief Summary

The hypothesis of this project is that replacing the current 7-day wear protocol with a 3-day wear protocol, while integrating less tooth movement per aligner (reduce the amount of activation per aligner) may produce more consistent and continues orthodontic forces, therefore, increase the predictability, accuracy and outcomes achieved for various types of tooth movements and enhance the rate of tooth movement with the Invisalign system

Condition or Disease Intervention/Treatment Phase
  • Device: Invisalign 7-day wear protocol
  • Device: Invisalign 3-day wear protocol
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
A Randomized Clinical Trial to Assess the Efficacy of Reducing the Aligners' Wear Protocol on the Predictability of Orthodontic Tooth Movement
Anticipated Study Start Date :
Aug 1, 2023
Anticipated Primary Completion Date :
Aug 1, 2025
Anticipated Study Completion Date :
Aug 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Group 1 (Control)

Device: Invisalign 7-day wear protocol
Clear Aligners' (Invisalign, Align technology, San Jose, Calif) 7-day wear protocol

Experimental: Group 2 (Experimental)

Device: Invisalign 3-day wear protocol
Clear Aligners' (Invisalign, Align technology, San Jose, Calif) 3-day wear protocol

Outcome Measures

Primary Outcome Measures

  1. predictability of the different orthodontic tooth achieved in each of the studies groups movements achieved at the end of treatment in each of the studied groups (3-day wear vs 7-day wear). [14 months]

    assess the influence of reducing the wear scheduled for Invisalign clear aligners, from 7- day wear to 3-day wear, on the predictability and accuracy of different orthodontic tooth movements by comparing the simulated predicted final outcomes to those achieved at the end of treatment between the two wear protocols.

  2. rate of tooth movement for the lower anterior teeth as detected by the consecutive scans captured by the scan box (Dental Monitoring®) in the first 8 weeks of treatment [2 months]

    compare and quantify the magnitude and rate of orthodontic tooth movement between the suggested (3-day) and conventional (7-day) wear protocols for the Invisalign® system using the Dental Monitoring superimposed scans and the data collected from their online platform in the first 8 weeks after Invisalign delivery.

Secondary Outcome Measures

  1. duration of treatment [14 months]

    the total time needed to complete treatment

  2. number of refinements and visits needed for each wear protocol. [14 months]

    the number of additional mid adjustment treatment scans needed for each included subject during the clinical trial duration

  3. Occlusal outcomes [14 months]

    The Peer Assessment rate and/or ABO grading system will be used to measure the final occlusal outcomes achieved in both groups for them to be compared.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 30 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Physically healthy with no relevant allergies or medical problems

  • Male or female between the age of 18 and 30.

  • Full permanent dentition except for the third molars

  • Class I crowded dentition primarily for the lower anterior teeth (moderate crowding - 4-6 mm - according to Little's Irregularity Index)

  • Good oral hygiene and absence of periodontal disease

  • Malocclusion to be treated with Invisalign aligners (SmartTrack)

  • Any ethnic group

Exclusion Criteria:
  • Orthognathic surgical cases

  • An extraction treatment plan

  • Poor oral hygiene

  • Patients with syndromes or craniofacial anomalies.

  • The use of any other orthodontic appliance than clear aligners' (Invisalign)

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • University of Florida
  • Align Technology, Inc.

Investigators

  • Principal Investigator: Sarah Abu Arqub, DDS, University of Florida

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Florida
ClinicalTrials.gov Identifier:
NCT05905224
Other Study ID Numbers:
  • IRB202300981
First Posted:
Jun 15, 2023
Last Update Posted:
Jun 18, 2023
Last Verified:
Jun 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
Yes
Keywords provided by University of Florida

Study Results

No Results Posted as of Jun 18, 2023